Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors
Authors:
- Gonzalo Rodríguez-BerrigueteGRGonzalo Rodríguez-Berriguete
- Laura GalvisLGLaura Galvis
- Benito FraileBFBenito Fraile
- Fermín R de BethencourtFBFermín R de Bethencourt
- Pilar Martínez-OnsurbePMPilar Martínez-Onsurbe
- Gabriel OlmedillaGOGabriel Olmedilla
- Ricardo PaniaguaRPRicardo Paniagua
- Mar RoyuelaMRMar Royuela
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 43 (2) , 229-237
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostateBMC Cancer, 2010
- Caspase-8 in cancer biology and therapyCancer Letters, 2009
- Caspases in apoptosis and beyondOncogene, 2008
- TNF/IL‐1/NIK/NF‐κB transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma)Histopathology, 2008
- Caspase activation cascades in apoptosisBiochemical Society Transactions, 2008
- Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapyOncogene, 2006
- The p38 transduction pathway in prostatic neoplasiaThe Journal of Pathology, 2005
- Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinomaEuropean Journal of Surgical Oncology, 2003
- Clinical significance of caspase-3 expression in pathologic-stage I, nonsmall-cell lung cancerInternational Journal of Cancer, 2001
- IL-2, Its Receptors, and bcl-2 and bax Genes in Normal, Hyperplastic and Carcinomatous Human Prostates: Immunohistochemical Comparative AnalysisGrowth Factors, 2000